Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5358-5363, October 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogdahn, U.
Right arrow Articles by Martin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogdahn, U.
Right arrow Articles by Martin, R.

Autocrine Tumor Cell Growth-inhibiting Activities from Human Malignant Melanoma

U. Bogdahn1, R. Apfel, M. Hahn, M. Gerlach, C. Behl, J. Hoppe and R. Martin

Department of Neurology, Cell Biology, and Neurochemistry Laboratories [U. B., R. A., M. G., C. B., R. M.], Institute of Genetics and Microbiology [C. B.], and Institute of Physiological Chemistry [J. H.], Julius-Maximilians-University, Würzburg, Josef-Schneider Strasse 11, D 8700 Federal Republic of Germany

Autocrine-secreted tumor cell growth-inhibiting activities were isolated from supernatants of a malignant melanoma cell line, HTZ 19-dM, established from a central nervous system melanoma metastasis. HTZ 19-dM was characterized by cyto- and immunocytochemistry and karyotyping; cells were propagated in defined serum-free tissue culture medium for up to 8 months. Supernatants were ultrafiltrated, dialyzed, lyophilized, and purified by Bio-Gel P-10 gel permeation chromatography, leading to three active fraction pools, MIAI [melanoma-inhibiting activity (MIA), 2 kDa), MIAII (Mr 11,500–17,000) and MIAIII (proteins at the cutoff of Bio-Gel P-10) inhibiting growth of 19-dM cells with 50% inhibitory concentrations of 0.79 µg/ml (MIAI), 0.13 µg/ml (MIAII), and 16.7 µg/ml (MIAII). MIAII could be further purified by reverse phase high pressure liquid chromatography; the main activity displayed a 50% inhibitory concentration of 0.33 µg/ml. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis one major band (molecular weight about 14,000) and two minor bands (up to Mr 17,000) were identified. Macromolecular synthesis was inhibited in 19-dM cells up to >99.5%; tumor stem cell colony formation was reduced by 99.89%; the inhibitory effect of MIAII was irreversible, nonsaturable, and partially antagonized by a serum factor (depending on purification stage). MIAII was heat stable (3 min at 100°C) and trypsin labile. The effect of MIAII on allogeneic neuroectodermal tumors was also investigated; proliferation of two of three malignant melanomas and two of four glioblastomas was inhibited up to 85.2%; proliferation of a neuroblastoma cell line could be inhibited to 33.8%, whereas normal fibroblasts and low grade gliomas were not influenced in their proliferation.

1 To whom requests for reprints should be addressed.

Received 3/ 9/89. Revised 6/22/89. Accepted 7/ 6/89.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
M. B. Faries, R. K. Gupta, X. Ye, E. C. Hsueh, and D. L. Morton
Melanoma-Inhibiting Activity Assay Predicts Survival in Patients Receiving a Therapeutic Cancer Vaccine After Complete Resection of American Joint Committee on Cancer Stage III Melanoma
Ann. Surg. Oncol., January 1, 2004; 11(1): 85 - 93.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Bosserhoff, M. Moser, J. Scholmerich, R. Buettner, and C. Hellerbrand
Specific Expression and Regulation of the New Melanoma Inhibitory Activity-related Gene MIA2 in Hepatocytes
J. Biol. Chem., April 18, 2003; 278(17): 15225 - 15231.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
R. Stoll, C. Renner, R. Buettner, W. Voelter, A.-K. Bosserhoff, and T. A. Holak
Backbone dynamics of the human MIA protein studied by 15N NMR relaxation: Implications for extended interactions of SH3 domains
Protein Sci., March 1, 2003; 12(3): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Deichmann, A. Benner, M. Bock, A. Jackel, K. Uhl, V. Waldmann, and H. Naher
S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma
J. Clin. Oncol., June 1, 1999; 17(6): 1891 - 1891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-F. Xie, S. Kondo, and L. J. Sandell
Regulation of the Mouse Cartilage-derived Retinoic Acid-sensitive Protein Gene by the Transcription Factor AP-2
J. Biol. Chem., February 27, 1998; 273(9): 5026 - 5032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Bosserhoff, Rüd. Hein, U. Bogdahn, and R. Buettner
Structure and Promoter Analysis of the Gene Encoding the Human Melanoma-inhibiting Protein MIA
J. Biol. Chem., January 5, 1996; 271(1): 490 - 495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.